Filing Details
- Accession Number:
- 0001140361-20-026482
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-24 18:10:24
- Reporting Period:
- 2020-11-20
- Accepted Time:
- 2020-11-24 18:10:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1661181 | Organogenesis Holdings Inc. | ORGO | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1069096 | Thompson Dean | C/O Avista Capital Partners 65 East 55Th Street, 18Th Floor New York NY 10022 | No | No | No | No | |
1374179 | F David Burgstahler | C/O Avista Capital Partners 65 East 55Th Street, 18Th Floor New York NY 10022 | No | No | No | No | |
1661187 | Avista Acquisition Corp. | 65 East 55Th Street 18Th Floor New York NY 10022 | No | No | No | No | |
1664173 | Avista Capital Partners (Offshore) Iv, L.p. | C/O Avista Capital Partners 65 East 55Th Street, 18Th Floor New York NY 10022 | No | No | No | No | |
1664176 | Avista Capital Partners Iv, L.p. | C/O Avista Capital Partners 65 East 55Th Street, 18Th Floor New York NY 10022 | No | No | No | No | |
1686388 | Avista Acquisition, Llc | 65 East 55Th Street 18Th Floor New York NY 10022 | No | No | No | No | |
1761175 | Avista Capital Managing Member Iv, Llc | C/O Avista Capital Partners 65 East 55Th Street, 18Th Floor New York NY 10022 | No | No | No | No | |
1761195 | Avista Capital Partners Iv Gp, L.p. | C/O Avista Capital Partners 65 East 55Th Street, 18Th Floor New York NY 10022 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2020-11-20 | 2,739 | $4.99 | 29,924,415 | No | 4 | P | Indirect | See Notes |
Class A Common Stock | Acquisiton | 2020-11-24 | 100 | $5.00 | 29,924,515 | No | 4 | P | Indirect | See Notes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Notes |
No | 4 | P | Indirect | See Notes |
Footnotes
- This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.
- The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.
- Represents an aggregate of 1,373 shares of Common Stock purchased by ACP Onshore and 1,366 shares of Common Stock purchased by ACP Offshore.
- Purchase prices range from $4.98 to $5.00 per share, inclusive.
- Represents an aggregate of 50 shares of Common Stock purchased by ACP Onshore and 50 shares of Common Stock purchased by ACP Offshore.
- Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.
- Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests